TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T01378 XX ID T01378 XX DT 18.11.1994 (created); ewi. DT 22.11.2010 (updated); din. CO Copyright (C), QIAGEN. XX FA E2F-I XX SY E2F-I; E2F-inhibitor. XX OS mouse, Mus musculus OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae XX FF inhibits E2F-binding to DNA; XX IN T01543 E2F-1; mouse, Mus musculus. IN T00221 E2F:DP; human, Homo sapiens. XX DR TRANSPATH: MO000025633. XX RN [1]; RE0000795. RX PUBMED: 1829698. RA Raychaudhuri P., Bagchi S., Devoto S. H., Kraus V. B., Moran E., Nevins J. R. RT Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes RL Genes Dev. 5:1200-1211 (1991). RN [2]; RE0001169. RX PUBMED: 1834862. RA Phelps W. C., Bagchi S., Barnes J. A., Raychaudhuri P., Kraus V., Muenger K., Howley P. M., Nevins J. R. RT Analysis of trans activation by human papilloma virus type 16 E7 and adenovirus 12S E1A suggests a common mechanism RL J. Virol. 65:6922-6930 (1991). RN [3]; RE0015322. RX PUBMED: 10090723. RA Zheng N., Fraenkel E., Pabo C. O., Pavletich N. P. RT Structural basis of DNA recognition by the heterodimeric cell cycle transcription factor E2F-DP RL Genes Dev. 13:666-674 (1999). XX //